Most of the drugs corresponding to GRIN2A are antidepressants as well as antipsychotics, such as apimostinel, esketamine, and haloperidol, which improve cognitive deficits caused by the early stages of Alzheimer’s disease (66, 67). This evidence concerns the gene GRIN2A and Cognitive impairment.